What is Cardiol Therapeutics Inc Class A (CRDL) stock price today?

Cardiol Therapeutics Inc Class A (CRDL) currently trades at $1.38 per share. The stock has a market capitalization of $156.35M and a P/E ratio of —x.

Is CRDL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cardiol Therapeutics Inc Class A has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

CRDL

Cardiol Therapeutics Inc Class A

NASDAQ: CRDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.38

+5.34% today

Updated 2026-04-30

Market cap

$156.35M

P/E ratio

—

P/S ratio

1,014.87x

EPS (TTM)

$-0.29

Dividend yield

—

52W range

$1 – $2

Volume

0.8M

Market cap

$156.35M

P/E ratio

—

P/S ratio

1,014.87x

EPS (TTM)

$-0.29

Dividend yield

—

52W range

$1 – $2

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$7.46

+440.58%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.23M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-22.82M	$-21.22M	$-36.68M	$-33.82M	$-7.21M
EPS	—	—	—	—	$-0.29
Free cash flow	$-27.30M	$-25.24M	$-25.08M	$-23.88M	$-5.23M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CRDL	$156.35M	17	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Cardiol Therapeutics Inc Class A trades at $1.38. Our Smart Value Score of 17/100 indicates the stock is weak.

Frequently asked questions

What is Cardiol Therapeutics Inc Class A's stock price?

Cardiol Therapeutics Inc Class A (CRDL) trades at $1.38.

Is Cardiol Therapeutics Inc Class A overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Cardiol Therapeutics Inc Class A (CRDL)?

The analyst target price is $7.46, representing +440.6% upside from the current price of $1.38.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1,014.87x

ROE-158.70%

Beta0.43

50D MA$1.17

200D MA$1.12

Shares out0.11B

Float0.10B

Short ratio—

Avg volume0.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CRDL vs LLY →CRDL vs JNJ →CRDL vs ABBV →Stock screener →